|
[1]
|
Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines
Experimental and Clinical Gastroenterology,
2023
DOI:10.31146/1682-8658-ecg-208-12-4-68
|
|
|
|
|
[2]
|
Further insights into the impact of rebamipide on gentamicin-induced nephrotoxicity in rats: modulation of SIRT1 and β-catenin/cyclin D1 pathways
Drug and Chemical Toxicology,
2023
DOI:10.1080/01480545.2022.2104867
|
|
|
|
|
[3]
|
Further insights into the impact of rebamipide on gentamicin-induced nephrotoxicity in rats: modulation of SIRT1 and β-catenin/cyclin D1 pathways
Drug and Chemical Toxicology,
2022
DOI:10.1080/01480545.2022.2104867
|
|
|
|
|
[4]
|
Management of patients with digestive diseases during the COVID-19 pandemic. Clinical Practice Guidelines by the Russian scientific medical society of internal medicine (RSMSIM) and the Gastroenterological Scientific Society of Russia (2nd edition)
Experimental and Clinical Gastroenterology,
2021
DOI:10.31146/1682-8658-ecg-187-3-5-82
|
|
|
|
|
[5]
|
Gastrointestinal symptoms in SARS-CoV‑2 infected: emphasis on increased mucosal permeability
Medical alphabet,
2021
DOI:10.33667/2078-5631-2021-20-13-20
|
|
|
|
|
[6]
|
Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis
Russian Journal of Gastroenterology, Hepatology, Coloproctology,
2021
DOI:10.22416/1382-4376-2021-31-4-70-99
|
|
|
|
|
[7]
|
Management of patients with digestive diseases during the COVID-19 pandemic: Clinical Practice Guidelines by the Gastroenterological Scientific Society of Russia
Experimental and Clinical Gastroenterology,
2020
DOI:10.31146/1682-8658-ecg-179-7-4-51
|
|
|
|